BidaskClub upgraded shares of Sabra Health Care REIT (NASDAQ:SBRA) from a strong sell rating to a sell rating in a research report sent to investors on Thursday, March 8th.
A number of other brokerages have also recently commented on SBRA. Zacks Investment Research cut Sabra Health Care REIT from a hold rating to a sell rating in a research note on Wednesday, January 17th. Mizuho set a $18.00 price target on Sabra Health Care REIT and gave the company a hold rating in a research note on Friday, February 23rd. ValuEngine cut Sabra Health Care REIT from a buy rating to a hold rating in a research note on Sunday, December 31st. Raymond James Financial reaffirmed a hold rating on shares of Sabra Health Care REIT in a research note on Wednesday, December 13th. Finally, SunTrust Banks set a $22.00 price target on Sabra Health Care REIT and gave the company a buy rating in a research note on Monday, January 22nd. Three investment analysts have rated the stock with a sell rating, six have issued a hold rating and four have assigned a buy rating to the stock. Sabra Health Care REIT presently has a consensus rating of Hold and an average price target of $24.10.
Sabra Health Care REIT (NASDAQ:SBRA) traded up $0.09 during trading on Thursday, reaching $17.90. 2,534,238 shares of the company’s stock were exchanged, compared to its average volume of 1,994,531. The company has a current ratio of 6.85, a quick ratio of 6.85 and a debt-to-equity ratio of 0.99. Sabra Health Care REIT has a 52 week low of $15.77 and a 52 week high of $29.10. The firm has a market cap of $3,190.78, a P/E ratio of 14.92, a PEG ratio of 2.42 and a beta of 0.75.
The firm also recently announced a quarterly dividend, which was paid on Wednesday, February 28th. Investors of record on Thursday, February 15th were paid a dividend of $0.45 per share. The ex-dividend date was Wednesday, February 14th. This represents a $1.80 dividend on an annualized basis and a yield of 10.06%. Sabra Health Care REIT’s payout ratio is 150.00%.
Hedge funds and other institutional investors have recently bought and sold shares of the stock. Ffcm LLC increased its stake in Sabra Health Care REIT by 1,297.4% during the 4th quarter. Ffcm LLC now owns 5,897 shares of the real estate investment trust’s stock worth $112,000 after purchasing an additional 5,475 shares in the last quarter. FNY Partners Fund LP bought a new stake in Sabra Health Care REIT during the 3rd quarter worth approximately $155,000. MANA Advisors LLC bought a new stake in Sabra Health Care REIT during the 4th quarter worth approximately $193,000. BB&T Securities LLC bought a new stake in Sabra Health Care REIT during the 3rd quarter worth approximately $200,000. Finally, Atria Investments LLC bought a new stake in Sabra Health Care REIT during the 4th quarter worth approximately $208,000. 88.91% of the stock is owned by institutional investors and hedge funds.
ILLEGAL ACTIVITY NOTICE: This piece of content was first reported by BBNS and is owned by of BBNS. If you are reading this piece of content on another publication, it was copied illegally and reposted in violation of U.S. and international trademark & copyright laws. The correct version of this piece of content can be accessed at https://baseballnewssource.com/2018/03/18/sabra-health-care-reit-sbra-lifted-to-sell-at-bidaskclub/2009478.html.
About Sabra Health Care REIT
Sabra Health Care REIT, Inc is a real estate investment trust. The Company, through its subsidiaries, owns and invests in real estate serving the healthcare industry. The Company’s segment includes investments in healthcare-related real estate properties. The Company’s primary business consists of acquiring, financing and owning real estate property to be leased to third-party tenants in the healthcare sector.
Receive News & Ratings for Sabra Health Care REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Health Care REIT and related companies with MarketBeat.com's FREE daily email newsletter.